$Melinta Therapeutics, Inc.(MLNT)$ 8-K/A [Amend] - Current report Filed: 2017-12-06 AccNo: 0001193125-17-362842 Size: 17 KBItem 9.01: Financial Statements and Exhibits 网页链接